Purpose: Familial renal glucosuria (FRG, OMIM #233100) is a rare but relatively benign genetic condition characterized by persistent isolated glucosuria with a normal blood glucose level. We report three additional SLC5A2 mutations and examine their phenotypic and genetic characteristics in a Korean FRG cohort. We also reviewed the literature and summarized the genotypes of all Korean patients with FRG. Methods: A genetic analysis was conducted by directly sequencing all 14 exons of the SLC5A2 gene and their flanking regions in six unrelated Korean children with FRG and their family members. Novel non-synonymous single-nucleotide polymorphisms were identified and compared with known mutations that are repeatedly detected in the Korean population. Results: We found two novel mutations [c.274G>A (G92S) and c.1168C>T (L390F)] and one known [c.1382G>A (S461N)] mutation in each family and one recurrent mutation [c.1346G>A (G449D) (rs768392222)] in two pedigrees. The recurrent G449D was predicted to be "possibly damaging, " with a score of 0.883 in Polyphen-2, while G92S, L390F, and S461N were predicted to be "probably dama ging, " with scores of 1.000, 0.999, and 0.996, respectively. Conclusions: Two novel, one previously reported, and one recurrent mutation were identified in six Korean FRG pedigrees as causative mutations of renal glucosuria. Sequence variations in the SLC5A2 gene were frequently detected in children with persistent isolated glucosuria. A long-term follow-up of this FRG cohort is needed to understand how these specific SGLT2 mutations impair kidney function and energy homeostasis.
Introduction
Familial renal glucosuria (FRG, OMIM #233100) is a rare genetic condition characterized by persistent isolated glucosuria with a normal glucose level in blood and a relatively benign condition 1, 2) . Mutations in the SLC5A2 gene that encodes glucose transporter in the renal proximal tubule are known to be a cause of this genetic condition and these mutations have been reported to be distributed across the entire gene region without a hot spot 3, 4) . The lower af finity, highcapacity sodiumglucose cotransporter 2 (SGLT2), located in the early proximal convoluted tubule segment S1, plays a major role in the glucose reabsorption mechanism 57) . SGLT2 enables glucose homeostasis by reabsor www.chikd.org bing the filtered glucose (approximately 180 g/day) and ex creting glucose <0.5 g/day in adults 6, 7) . The SLC5A2 gene is mapped to 16p11.2 and has 14 exons encoding 672 amino acids 8, 9) . The degree of glucosuria depends on the mutation site, type and zygosity, so the clinical course varies accor ding to the affected individual. Therefore, the codominance mode of inheritance with variable penetrance has been suggested 1, 2) . Here, we added six patients to the Korean FRG cohort, reporting two additional novel SLC5A2 mutations and reviewed the genetic characteristics in this study and the literature.
Materials and methods

Study population
Blood samples from six Korean children and their fa milies with isolated glucosuria were collected from May 2014 to June 2016 for the SLC5A2 mutation analysis. Written informed consent was obtained from all subjects and their family members for the molecular diagnostic tests when ever possible. This study was approved by the Institutional Review Board of Busan Paik Hospital and conducted ac cording to the guidelines of the Declaration of Helsinki.
Five probands and one child were incidentally found to have glucosuria during a school health examination survey and a fever workup, respectively. Their mean age (four males and two females) was 10.8 years (range, 714 years). Diag nostic criteria were: (1) total 24hour urine glucose excre tion >0.5 g/1.73 m 2 ; (2) normal glucose metabolism; 3)
normal renal function without other pathological signs, such as hematuria, proteinuria, hyperphosphaturia, hyper calciuria, or metabolic acidosis.
SLC5A2 mutation analysis
Human genomic DNA was prepared from peripheral blood samples using the QIAamp DNA Blood Mini Kit (Qiagen, Hilden, Germany When an identical mutation has been reported separately over three times, we consider it as a recurrent (nonrandom) mutation.
3. Literature review and in silico prediction of altered protein function A comprehensive review of the literature and a mutation database (Human Gene Mutation Database, http//www. hgmd.org) was conducted regarding the SLC5A2 sequence variations in FRG. To predict the deleterious effect of se quence variations, the substitutions found in all sequence variations detected in the Korean FRG cohort in this study and the literature were submitted to the webbased pro grams Sorting Intolerant From Tolerant (http://sift.jcvi. org) and Polyphen2 (http://genetics.bwh.harvard.edu/ pph2) and analyzed.
Results
Phenotypic analysis
None of probands in the FRG family had symptoms or signs of diabetes mellitus. No abnormal results were ob served in the biochemistry, electrolytes, or a urinalysis, except glucosuria. No growth disturbances, polydipsia, polyuria, or dehydration were detected. clinical characteristics of these probands. No aminoaciduria was detected in the tested probands (patients 2, 3, and 4).
SLC5A2 mutation and in silico analyses
We found two novel mutations (c.274G>A (G92S) and c.1168C>T (L390F)) and one known mutation (c.1382G>A (S461N)) mutation in each family and one recurrent muta tion (c.1346G>A (G449D) (rs768392222)) in two pedigrees (Fig. 1) . The two novel variants were not found in any varia tion databases, including dbSNP, ExAc, and 1000G, or the literature (Table 2) . One pedigree revealed no mutation in the coding sequence or its flanking regions. The recur rent G449D was predicted to be 'possibly damaging' with a score of 0.883 in Polyphen2, while the novel G92S and L390F and the known S461N were predicted to be 'probably dama ging' with scores of 1.000, 0.999, and 0.996, respectively.
Discussion
In this study, sequence variations were detected frequ ently (83%, 5/6) by mutation analysis of the SLC5A2 gene in six unrelated families with persistent isolated glucosuria. Two novel (G92S and L390F), one known (S461N), and one recurrent (G449D) mutation were identified as causative mutations of renal glucosuria. Two novel and one known sequence variations were considered probably damaging, with a higher impact score in the prediction tools, com pared with that of the known recurrent mutation. Despite a thorough evaluation of one pedigree with glucosuria, no mutations were detected in the entire coding region or adjacent intronic segments. A heterozygous large deletion or unknown mutation may be present in the other associ ated gene epigenetic alterations. In previous studies, wild type individuals also had the FRG pedigree 1, 8) . To date, over 70 different SLC5A2 gene mutations have been reported and most are missense mutations and are suggested to be private (restricted to a single individual or pedigree) 3, 1014) . However, some of the mutations, such as IVS7+5G>A (c.885+5G>A), G449D (rs768392222), and P246S (rs773359240), have been reported recurrently 3, 12, 14) . In a study with a cohort of 23 Korean children with FRG, 19 mutations were detected, which were also private or novel, except for the recurrent G449D in seven pedigrees 14) . The present study reconfirms that most of SLC5A2 gene mutations are private and that G449D is a recurrent mu tation in Korean FRG. IVS7+5G>A has been reported with the highest frequency in other ethnic groups 1, 15) . Zhao et al. reported a 22bp deletion in intron 7 (c.886(10_31)del), which was suggested to be the second highfrequency mu tation (eight Chinese families) following IVS7+5G>A; thus, they concluded that this high frequency deletion in intron 7 should be screened in more patients with FRG and uni allelic or negative SLC5A2 mutations 9) . Although we rean alyzed the flanking regions of intron 7, we could not find any mutations in our FRG cohort.
FRG is generally an asymptomatic disorder except for glucosuria. Furthermore, glucosuria has been reported to be mild in most patients with FRG. However, some cases, especially those with homozygous or compound hetero zygous mutations, have heavy glucosuria 1) . In those cases, severe glucosuria can be accompanied by generalized ami noaciduria 16) . Hyperuricosuria and hypercalciuria can also be secondary signs of FRG 1719) . In this study, only one of six patients with FRG showed severe glucosuria, but ami no aciduria, hyperuricosuria, or hypercalciuria was not present. One patient with the recurrent G449D mutation showed severe glucosuria, whereas another patient with the same mutation showed only mild glucosuria, indicating the variable expressivity of this genetic disorder.
A new class of antihyperglycemic drug targeting the SGLT2 has been introduced to treat type 2 diabetes. This new class of antihyperglycemic drug has several advant ages to deliver a beneficial effect on body weight and blood pressure. Use of SGLT2 inhibitors to diabetes mimics the beneficial effect of dysfunctional SGLT2 in FRG individuals. SGLT2 inhibitors can cause the same kinds of complica tions such as dehydration and urinary infections, which have been also reported in the severe form of FRG 3, 20) . In hibition or dysfunction of SGLT2 has pleiotropic effects on renal physiology 7, 21, 22) . The longterm outcome of patients with FRG is excellent, but the beneficial effect on metabolic homeostasis is unclear 11, 23, 24) . Thus, a longterm followup is needed to elucidate the lifelong consequences of inhibi ting or altering SGLT2. In addition, the mutation profiles of SLC5A2 gene could provide useful clues for the protein function and new drug targets.
In summary, we identified five mutations, including two novel, one known, and one recurrent missense mutation, in six Korean FRG pedigrees. This study expands the know ledge about the genetic characteristics of SLC5A2 in Korean FRG. A longterm followup of this FRG cohort is needed to understand how these specific SGLT2 mutations impair kidney function and energy homeostasis and to predict which domains would be targets of SGLT2 inhibitors.
